Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)
Clinical trial NCT00712790 · COMPLETED
Trial details
- NCT number
- NCT00712790
- Sponsor
- Singapore Clinical Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2009-06-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.